Related references
Note: Only part of the references are listed.Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives
Newman Yeilding et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010 (2011)
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease
Alessandra Geremia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab
Jacqueline M. Benson et al.
NATURE BIOTECHNOLOGY (2011)
The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
Paola Di Meglio et al.
PLOS ONE (2011)
Localization of tumour necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor
M. KRISTENSEN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells
Valerie Staudt et al.
IMMUNITY (2010)
Cytokine Requirements for the Differentiation and Expansion of IL-17A-and IL-22-Producing Human Vγ2Vδ2 T Cells
Kristin J. Ness-Schwickerath et al.
JOURNAL OF IMMUNOLOGY (2010)
Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab
Jinquan Luo et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Antibodies to watch in 2010
Janice M. Reichert
MABS (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
IL-17-producing γδ T cells
Rebecca L. O'Brien et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Plasticity of CD4+ T Cell Lineage Differentiation
Liang Zhou et al.
IMMUNITY (2009)
IL-23 modulates CD56+/CD3- NK Cell and CD56+/CD3+ NK-like T Cell function differentially from IL-12
Diederik van de Wetering et al.
INTERNATIONAL IMMUNOLOGY (2009)
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
Alice Gottlieb et al.
LANCET (2009)
Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
Sara Trifari et al.
NATURE IMMUNOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cutting edge:: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion
Aleksandra V. Rachitskaya et al.
JOURNAL OF IMMUNOLOGY (2008)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12
Patrick J. Lupardus et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M. Segal et al.
LANCET NEUROLOGY (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
Dirk Koczan et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Interleukin-12, interleukin-23, and psoriasis: Current prospects
Dorothea C. Torti et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research
E. Guttman-Yassky et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis
Francesca Capon et al.
HUMAN GENETICS (2007)
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Nicholas J. Wilson et al.
NATURE IMMUNOLOGY (2007)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
Psoriasis has a major secondary impact on the lives of family members and partners
A. M. Eghlileb et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
The family impact of skin diseases: the Greater Patient concept
M. K. A. Basra et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes
Michele Cargill et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Cutting edge: Regulatory T cells induce CD4(+)CD25(-)Foxp3(-) T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta
LiLi Xu et al.
JOURNAL OF IMMUNOLOGY (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Prevalence and correlates of suicidal ideation among patients with skin disease
A Picardi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Follicular B helper T cells in antibody responses and autoimmunity
CG Vinuesa et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity
O Arican et al.
MEDIATORS OF INFLAMMATION (2005)
Medical progress - Psoriasis
MP Schon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human
S Vanden Eijnden et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Human antibodies from transgenic animals
N Lonberg
NATURE BIOTECHNOLOGY (2005)
Paul Ehrlich - in search of the magic bullet
F Winau et al.
MICROBES AND INFECTION (2004)
Divergent pro- and Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation
CA Murphy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity
SE Jacob et al.
MEDIATORS OF INFLAMMATION (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination
B Gran et al.
JOURNAL OF IMMUNOLOGY (2002)
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R
C Parham et al.
JOURNAL OF IMMUNOLOGY (2002)
Psoriasis - epidemiology and clinical spectrum
E Christophers
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2001)
IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs
K Shigehara et al.
JOURNAL OF IMMUNOLOGY (2001)
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
B Oppmann et al.
IMMUNITY (2000)
Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12
C Yoon et al.
EMBO JOURNAL (2000)
Share Paper
